MarketGrader Israel All-Cap 40 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
TEVA Teva Pharmaceutical Industries Limited 50.3 ¤44,899 IL
LUMI.IL Bank Leumi Le-Israel B.M. 68.2 ¤38,620 IL
POLI.IL Bank Hapoalim BM 67.7 ¤35,120 IL
CHKP Check Point Software Technologies Ltd. 59.2 ¤14,058 IL
MMHD.IL Menora Mivtachim Holdings Ltd. 62.4 ¤11,228 IL

Five Smallest Companies
Symbol Name Grade Market Cap Country
IMCO.IL Imco Industries Ltd. 36.7 ¤43 IL
RDCM RADCOM Ltd. 36.1 ¤170 IL
PCBT.IL PCB Technologies Ltd. 48.2 ¤300 IL
MTRD.IL Meitav Trade Investments Ltd. 73.5 ¤354 IL
TTAM.IL Tiv Taam Holdings 1 Ltd. 59.7 ¤417 IL

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
CHKP Check Point Software Technologies Ltd. 59.2 35 IL
ITRN Ituran Location and Control Ltd. 79.4 35 IL
POLI.IL Bank Hapoalim BM 67.7 21 IL
LUMI.IL Bank Leumi Le-Israel B.M. 68.2 18 IL
HLAN.IL Hilan Ltd. 56.0 17 IL
NICE NICE Ltd. Sponsored ADR 58.0 14 IL
FBRT.IL FMS Enterprises Migun Limited 58.5 13 IL
MMHD.IL Menora Mivtachim Holdings Ltd. 62.4 13 IL
ONE.IL One Software Technologies Ltd. 59.5 12 IL
IDIN.IL I.D.I. Insurance Company Ltd. 65.7 11 IL
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤5,042
Median Market Cap ¤1,040
Avg. 3 Mo. Dollar Vol. ¤17,463,472
Avg. 3 Mo. Trading Vol. 466,207
Last Rebalance Date 03/23/2026
Companies Replaced 19
Biggest Sector Increase Consumer Staples
Biggest Sector Decrease Industrials

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 15.4
Forward P/E Ratio (12 Mo.) 15.3
Price/Book Ratio 3.3
Avg. Revenue Chg. - 3 Yr 50.0%
Avg. Op. Income Chg. - 3 Yr. 96.3%
Avg. EPS Growth - 3 Yr. 24.8%
Avg. EPS Growth - 1 Yr. 21.4%
Avg. Operating Margin 18.4%
Avg. LT Debt to Total Capital 33.3%
Avg. Return on Equity 20.3%
Dividend Yield 2.8%
Index Average Grade
Israel All-Cap 40 Index 62.78
Country Breakdown
Israel 97.5%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE